Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

Molecular mechanism of bacteriophage tail spike proteins in bacterial infection

Description

Antibiotic resistance in pathogenic microorganisms is rapidly increasing worldwide which urgently calls for novel agents and innovative solutions for the treatment of bacterial infections. Bacteriophages (phages) infect and inactivate bacteria in a highly specific manner. Therefore, exploitation of phages represents a highly promising alternative to antibiotics to detect, identify and combat human bacterial pathogens.

For potential applications in medicine, high specificity of a phage for its bacterial host is a tremendous advantage in order to avoid broad killing of commensal human bacteria. However, the infection mechanism remains poorly characterized to date which hampers development of phage-derived solutions. Limitations in understanding the process on a quantitative, molecular level is mainly due to lack of suitable analytical methods.

Tail spike proteins (TSPs) are specialized hydrolytic phage proteins located at the end of the phage tail, which govern the first steps in bacterial infection by the phage. Initial events in infection involve binding of the phage TSPs to the bacterial surface followed by degradation of the bacterial polysaccharide layer.

We aim at understanding the molecular basis of these first steps in infection through development of novel, quantitative bioanalytical methods using TSPs produced in a phage-free context. Elucidation of molecular details of the infection process is crucial for understanding the mode of action and phage specificity for further engineering of TSPs for broad, potential applications in analytics and medicine. Methods developed shall be applicable for other phage TSPs.

The project is performed in synergy with Prof. Dr. Lars Fieseler, Head of Food Microbiology Research Group (ILGI) and Dr. Sabina Gerber, Head of Bioanalytics Research Group (ICBT). Tackling the questions specified is greatly strengthened by combined expertises in microbiology, biochemistry and bioanalytics.

Key data

Co-Projectlead

Project team

Angela Nauer, Leandra Knecht

Project status

completed, 06/2020 - 12/2021

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT); Institute of Food and Beverage Innovation (ILGI)

Funding partner

Internal

Project budget

200'000 CHF

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.